Old Web
English
Sign In
Acemap
>
authorDetail
>
Steve Lenger
Steve Lenger
GE Healthcare
Molecular biology
Biology
Genome editing
car t cells
CRISPR
3
Papers
101
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
DEVELOPMENT OF A NEXT GENERATION ALLOGENEIC CAR-T CELL PLATFORM WITHOUT GENE EDITING: PS1210
2019
Panagiota A. Sotiropoulou
Alexandre Michaux
Susanna Raitano
Simon Bornschein
Jennifer Bolsée
Steve Lenger
Hidevaldo Machado
J.D. Moore
David E. Gilham
Show All
Source
Cite
Save
Citations (0)
Next Generation NKG2D-based CAR T-cells (CYAD-02): Co-expression of a Single shRNA Targeting MICA and MICB Improves Cell Persistence and Anti-Tumor Efficacy in vivo
2019
Blood
Martina Fontaine
Benjamin Demoulin
Simon Bornschein
Susanna Raitano
Steve Lenger
Hidevaldo Machado
Jonathan D. Moore
Panagiota A. Sotiropoulou
David E. Gilham
Show All
Source
Cite
Save
Citations (2)
Systematic analysis of CRISPR-Cas9 mismatch tolerance reveals low levels of off-target activity.
2015
Journal of Biotechnology
Emily Anderson
Amanda Haupt
John A. Schiel
Eldon T. Chou
Hidevaldo Machado
Žaklina Strezoska
Steve Lenger
Shawn McClelland
Amanda Birmingham
Annaleen Vermeulen
Anja van Brabant Smith
Show All
Source
Cite
Save
Citations (99)
1